Skip to main content
. 2019 Mar 12;8(3):347. doi: 10.3390/jcm8030347

Table 8.

Meta-analysis results of gene variants from genome-wide association studies showing significant p-value (<5 × 10−8).

Author, Year No. of Studies Comparison OR (95% CI) p-Value Model Disease Ethnicity I2 (%) Power OR 1.2 Power OR 1.5 FPRP Values at Prior Probability BFDP 0.001 BFDP 0.000001
OR 1.2 OR 1.5
0.001 0.000001 0.001 0.000001
Bowes J, 2014 [47S] 4 T vs. C 1.32 (1.21–1.45) 1.49 × 10−9 - PsA Caucasian 0.023 0.996 0.000 0.228 0.000 0.007 0.023 0.001 0.349
Gregersen PK, 2012 [48S] 3 T vs. C 1.71 (1.44–2.02) 3.72 × 10−10 - MG North European 0.000 0.062 0.018 0.947 0.000 0.004 0.000 0.000 0.095
Thompson SD, 2010 [49S] 2 additive 1.64 (1.44–1.87) 1.90 × 10−13 - JIA Initial + Replication 0.000 0.091 0.000 0.088 0.000 0.000 0.000 0.000 0.000
Coenen MJ, 2009 [50S] 2 T vs. C 1.67 (1.52–1.84) 2.0 × 10−27 R RA Caucasian European(miao)(Dutch+ UK) NA NA NA NA NA NA NA 0.000 0.000

RA, rheumatoid arthritis; PsA, psoriatic arthritis; MG, myasthenia gravis; JIA, juvenile idiopathic arthritis; OR, odds ratio; R, random; S, supplementary; FPRP, false-positive report probability; BFDP, Bayesian false discovery probability. Each comparison of genetic associations was regarded as noteworthy when FPRP of <0.2 or BFDP of <0.8 or both are fulfilled and the values were bolded when the results are significant by FPRP or BFDP. NAs are expressed when information is not available by FPRP calculations.